HHS Hits Back At AstraZeneca's Challenge To Drug Price Rule

By Hailey Konnath · November 2, 2023, 10:23 PM EDT

The federal government has urged a Delaware federal judge not to block the Inflation Reduction Act's provision allowing it to negotiate drug prices with pharmaceutical companies, arguing that AstraZeneca doesn't have...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

AstraZeneca Pharmaceuticals LP v. Becerra et al

Case Number

1:23-cv-00931

Court

Delaware

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

August 25, 2023

Recent Articles By Hailey

November 14, 2024
Ex-Ga. Rep. Doug Collins To Head Trump's Veterans Affairs
November 12, 2024
Trump Taps Elon Musk To Head New 'Gov't Efficiency' Dept.
November 04, 2024
Kroger, State AGs Finalize Sprawling $1.37B Opioid Deal
October 24, 2024
McDonald's Customers File First Suits Over E. Coli Outbreak
October 23, 2024
TriZetto Gets New Damages Trial After Ax Of $200M Awards
October 21, 2024
Google, Meta Want Out Of GoodRx Health Data Sharing Suit
October 18, 2024
HHS Slams Hackensack Meridian's Chevron-Inspired Suit
October 08, 2024
Cedars-Sinai OB-GYN Accused Of Abusing, Harassing Patients
October 08, 2024
Apple Loses Bid For Jury Trial In Masimo Trade Secrets Fight
October 07, 2024
Mednax Gets Final OK For $6M Data Breach Settlement